Total Receivables - Ryvu Therapeutics SA (WSE:RVU) - Alpha Spread
R

Ryvu Therapeutics SA
WSE:RVU

Watchlist Manager
Ryvu Therapeutics SA
WSE:RVU
Watchlist
Price: 54.1 PLN -1.64% Market Closed
Market Cap: 1.3B PLN
Have any thoughts about
Ryvu Therapeutics SA?
Write Note

Ryvu Therapeutics SA
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Ryvu Therapeutics SA
Total Receivables Peer Comparison

Comparables:
I
IGN
M
MDB
S
SLV

Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
R
Ryvu Therapeutics SA
WSE:RVU
Total Receivables
zł35.3m
CAGR 3-Years
70%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
I
Inno-Gene SA
WSE:IGN
Total Receivables
zł1.4m
CAGR 3-Years
-45%
CAGR 5-Years
-11%
CAGR 10-Years
4%
M
Medicofarma Biotech SA
WSE:MDB
Total Receivables
zł582.5k
CAGR 3-Years
57%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
S
Selvita SA
WSE:SLV
Total Receivables
zł82.5m
CAGR 3-Years
11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Ryvu Therapeutics SA's Total Receivables?
Total Receivables
35.3m PLN

Based on the financial report for Mar 31, 2024, Ryvu Therapeutics SA's Total Receivables amounts to 35.3m PLN.

What is Ryvu Therapeutics SA's Total Receivables growth rate?
Total Receivables CAGR 5Y
-4%

Over the last year, the Total Receivables growth was 38%. The average annual Total Receivables growth rates for Ryvu Therapeutics SA have been 70% over the past three years , -4% over the past five years .

Back to Top